pLenti-hACE2-hygro Citations (4)
Originally described in: Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.Daniloski Z, Jordan TX, Wessels HH, Hoagland DA, Kasela S, Legut M, Maniatis S, Mimitou EP, Lu L, Geller E, Danziger O, Rosenberg BR, Phatnani H, Smibert P, Lappalainen T, tenOever BR, Sanjana NE Cell. 2020 Oct 24. pii: S0092-8674(20)31394-5. doi: 10.1016/j.cell.2020.10.030. PubMed Journal
Articles Citing pLenti-hACE2-hygro
| Articles |
|---|
The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
Daniloski Z, Jordan TX, Ilmain JK, Guo X, Bhabha G, tenOever BR, Sanjana NE.
Elife. 2021 Feb 11;10. pii: 65365. doi: 10.7554/eLife.65365.
PubMed
Associated Plasmids |
| USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle. Song N, Deng L, Zeng L, He L, Liu C, Liu L, Fu R. Mol Carcinog. 2023 Oct;62(10):1487-1503. doi: 10.1002/mc.23591. Epub 2023 Jun 14. PubMed |
| PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection. Xu D, Jiang W, Wu L, Gaudet RG, Park ES, Su M, Cheppali SK, Cheemarla NR, Kumar P, Uchil PD, Grover JR, Foxman EF, Brown CM, Stansfeld PJ, Bewersdorf J, Mothes W, Karatekin E, Wilen CB, MacMicking JD. Nature. 2023 Jul;619(7971):819-827. doi: 10.1038/s41586-023-06322-y. Epub 2023 Jul 12. PubMed |
| Disruptive 3D in vitro models for respiratory disease investigation: A state-of-the-art approach focused on SARS-CoV-2 infection. Seixas ML, Bartolomeo CS, Lemes R, Nicoliche T, Okuda LH, Martins L, Ureshino R, Prado CM, Liguori TTA, Liguori GR, Stilhano RS. Biomater Biosyst. 2023 Jul 16;11:100082. doi: 10.1016/j.bbiosy.2023.100082. eCollection 2023 Sep. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.